An expert group of healthcare professionals has developed a practical guide for nutrition support and the use of oral nutritional supplements (ONS) in patients with severe chronic kidney disease (CKD).
Undernutrition is associated with poor outcomes in patients with chronic kidney disease (CKD) and can occur in 20%-50% of cases, depending on the stage of the disease1,2. Despite evidence supporting nutritional interventions in stage 4/5 CKD3, UK guidelines are lacking implementation strategies and current international recommendations4 are not tailored to the dietetic-led nutrition services prominent in the UK.
The best practice consensus guide (PDF, 172KB) ‘Consensus statement on nutrition support and the use of oral nutritional supplements in patients with stages 4-5 chronic kidney disease’, supported by Abbott, has been developed by an expert group of renal dietitians and a GP* in collaboration with the Renal Nutrition Group (RNG) of the British Dietetic Association. This step-by-step flowchart has been designed to support members of the multi-disciplinary team (MDT) identify, assess and manage undernutrition in patients with severe CKD (stage 4/5), including those on dialysis. It brings all the information together in a concise format that is easy to use on a day-to-day basis, including recommendations for screening, assessment and diagnosis, suggested interventions and monitoring procedures.
Click here to download the guide (PDF, 172KB)
* The group was chaired and facilitated by Helen MacLaughlin from King’s College Hospital. The other members of the group include Harriet Williams, Chair of the RNG and based at Bangor Hospital; Jan Flint, Royal Free Hospital; Karen Magee, Belfast City Hospital; Kevin Jesty, Royal Berkshire Hospital; Lakshmi Chandrasekharan, Southend University Hospital; Dr Rob Hicks, GP locum and broadcaster; Ruth Kander, Imperial College Hospital.
The Renal Nutrition Group (RNG) is for registered dietitians who work or have an interest in the specialist field of renal medicine and nutrition through clinical practice or research. The RNG acts as the source of expertise in renal nutrition in the UK. Established in 1970, it is committed to delivering accurate, comprehensive information to facilitate standardised practice and demonstrate clinical effectiveness in renal dietetics.
1. Steiber AL et al. JPEN 2014;38:418-426.
2. Chung S et al. OJIM 2012;2:89-99.
3. Ash S et al. Nutrients 2014;6:416-451.
4. Ikizler TA et al. Kidney Int 2013;84:1096-1107.
Muscle strength is important for patients' quality of life. Muscle loss naturally decreases with age and can have devasating consequences. However, muscle loss can be reversed with early nutritional intervention.
A multi-disciplinary group of healthcare professionals has developed a practical guide to support symptom identification, assessment and management of symptoms of gastrointestinal (GI) intolerance in malnourished adults in the community.
The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,<sup>9-27</sup> Watch this short video to learn more about the benefits of HMB.
UK-N/A-2200387 (V2) | October 2023
SESSION TIMEOUT
You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.
You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.
Stay Connected